Biocon trades higher on the bourses

29 Apr 2020 Evaluate

Biocon is currently trading at Rs. 360.75, up by 8.65 points or 2.46% from its previous closing of Rs. 352.10 on the BSE.

The scrip opened at Rs. 367.00 and has touched a high and low of Rs. 367.00 and Rs. 356.50 respectively. So far 29284 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 367.80 on 20-Apr-2020 and a 52 week low of Rs. 211.30 on 20-Aug-2019.

Last one week high and low of the scrip stood at Rs. 367.50 and Rs. 339.45 respectively. The current market cap of the company is Rs. 42252.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 21.64% and 17.70% respectively.

Biocon and Mylan N.V. have launched Fulphila, a biosimilar to Neulasta (pegfilgrastim). Fulphila is approved by Health Canada to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-neoplastic drugs.

The approval of Fulphila was based on a comprehensive package of analytical, nonclinical and clinical data, which confirmed that the product is highly similar to Neulasta and no clinically meaningful differences in terms of safety and efficacy exist.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

395.70 3.55 (0.91%)
19-Dec-2025 11:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1746.05
Dr. Reddys Lab 1273.70
Cipla 1505.60
Zydus Lifesciences 913.05
Lupin 2117.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×